References
- Abbott, F. V., & Fraser, M. I. (1998). Use and abuse of over-the-counter analgesic agents. Journal of Psychiatry and Neuroscience, 23, 13–34.
- Aktories, K. (2009). Allgemeine und spezielle Pharmakologie und Toxikologie. München: Urban und Fischer.
- Clive, D. M., & Stoff, J. S. (1984). Renal syndromes associated with nonsteroidal anti-inflammatory drugs. New England Journal of Medicine, 310, 563–572.
- Coman, O. A. (2008). Recent data on cannabinoids and their pharmacological implications in neuropathic pain. Journal of Medicine and Life, 1, 365–367.
- DHS (Deutsche Hauptstelle gegen die Suchtgefahren e.V.). (2000). Drogenabhängigkeit. Eine Information für Ärzte. Hamm.
- FDA (Food and Drug Administration). (2011, January). FDA News Release. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm239894.htm
- Flower, R. J., & Vane, J. R. (1972). Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature, 240, 410–411.
- Franceschi, F., Buccelletti, F., Marsiliani, D., Carroccia, A., Giupponi, B., De Marco, G., Gilardi, E., Merra, G., Mancini, F., Potenza, A., Giannuzzi, R., Calcinaro, S., Marini, M., & Gentiloni Silveri, N. (2010). Acetaminophen plus codeine compared to ketorolac in polytrauma patients. European Review for Medical and Pharmacological Sciences, 14, 629–634.
- Good, P. (2009). Did acetaminophen provoke the autism epidemic? Alternative Medicine Review, 14,364–372.
- The Governmental Portal of the Republic of Uzbekistan. (2011). Statistical information. Retrieved from http://www.gov.uz/en/helpinfo/population_labour/2622
- Heimer, R. (2011). HIV/AIDS in Russia: Past, present, and future. Lecture in Center for Interdisciplinary Research on AIDS (CIRA) at Yale University. New Haven, CT: Yale University.
- Heinz, A., Denke, C., & Ernst, G. (1999). Drug-induced headache – pathomechanisms of addiction. Schmerz, 13, 304–314.
- Păunescu, H., Coman, O. A., Coman, L., Ghita, I., Georgescu, S. R., Draghia, F., & Fulga, I. (2011). Cannabinoid system and cyclooxygenases inhibitors. Journal of Medicine and Life, 4, 11–20.
- Pelissier, T., Alloui, A., Paeile, C., & Eschalier, A. (1995). Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors. Neuroreport, 6, 1546–1548.
- Rote Liste. (2010). Arzneimittelverzeichnis für Deutschland. Frankfurt am Main: Rote Liste Service GmbH.
- Schneidereit, M. (2000). Psychotrope Wirkungen von Paracetamol, Coffein und der Kombination aus beiden Substanzen: Eine Humanstudie. Berlin: Mensch & Buch Verlag.
- Tan, S. C., New, L. S., & Chan, E. C. (2008). Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine. Toxicology Letters, 180, 174–181.
- Turaeva, M. ( in preparation). The trends and trajectories of contemporary HIV epidemic in Uzbekistan: cultural and behavioural patterns.
- UNODC. (2010). World drug report. Blue Ridge Summit, PA: United Nations Publication.